Abstract: The present invention relates to imidazo[4,5-c]pyridine compounds and pharmaceutical compositions for the treatment or prevention of viral infections, wherein the imidazo[4,5-c]pyridine compounds have the formula:
Type:
Grant
Filed:
May 19, 2009
Date of Patent:
July 15, 2014
Assignees:
Gilead Sciences, Inc., K.U. Leuven Research & Development, Gerhard Puerstinger
Inventors:
Johan Neyts, Gerhard Pürstinger, Erik De Clercq
Abstract: A crystalline compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections Methods of making and formulating crystalline compound (1) are provided.
Type:
Application
Filed:
December 23, 2011
Publication date:
May 3, 2012
Applicants:
Gilead Sciences, Inc., Gerhard Puerstinger, K.U. Leuven Research & Development
Inventors:
Eric D. Dowdy, Kenneth M. Kent, Norma J. Tom, Vahid Zia
Abstract: A compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections Methods of making and formulating compound (1) are provided.
Type:
Grant
Filed:
February 18, 2010
Date of Patent:
June 7, 2011
Assignees:
Gilead Sciences, Inc., K.U. Leuven Research & Development, Gerhard Puerstinger
Inventors:
Steven S. Bondy, David A. Oare, Winston C. Tse
Abstract: A compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections Methods of making and formulating compound (1) are provided.
Type:
Grant
Filed:
July 6, 2007
Date of Patent:
July 13, 2010
Assignees:
Gilead Sciences, Inc., K.U. Leuven Research & Development, Gerhard Puerstinger
Inventors:
Steven S. Bondy, Terrence C. Dahl, David A. Oare, Reza Oliyai, Winston C. Tse, Vahid Zia
Abstract: A compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections Methods of making and formulating compound (1) are provided.
Type:
Application
Filed:
February 18, 2010
Publication date:
June 17, 2010
Applicants:
Gilead Sciences, Inc., K.U. Leuven Research & Development, Gerhard Puerstinger
Inventors:
Steven S. Bondy, Terrenc C. Dahl, David A. Oare, Reza Oliyai, Winston C. Tse, Vahid Zia
Abstract: The present invention relates to pharmaceutical compositions for the treatment of prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyrimidine having the general formula (A), wherein the substituents are described in the specification. The invention also relates to processes for the preparation of compounds according to the invention having above mentioned general formula, their pharmaceutically acceptable formulations and their use as a medicine or to treat or prevent viral infections.
Type:
Application
Filed:
July 26, 2005
Publication date:
August 20, 2009
Applicants:
Gilead Sciences, Inc., K.U. Leuven Research & Development, Gerhard Puerstinger
Inventors:
Gerhard Puerstinger, Choung U. Kim, Johan Neyts, David A. Oare
Abstract: A crystalline compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections Methods of making and formulating crystalline compound (1) are provided.
Type:
Application
Filed:
July 3, 2008
Publication date:
February 5, 2009
Applicants:
Gilead Sciences, Inc., K.U. Leuven Research & Development, Gerhard Puerstinger
Inventors:
Eric D. Dowdy, Kenneth M. Kent, Norma J. Tom, Vahid Zia
© 2026 Justia
